Search Results

COMPANY SPOTLIGHT - Novo Nordisk.

Subjects: RESEARCH & development partnership; DRUG development; AUTOIMMUNITYNOVO Nordisk A/S; VLST Corp.

• Source: PharmaWatch: Biotechnology; Feb2009, Vol. 8 Issue 2, p22-27, 6p, 3 Charts

Record details

MULTIPLE SCLEROSIS.

Subjects: MULTIPLE sclerosis; SPINAL cord; AUTOIMMUNITY

• Source: Multiple Sclerosis Annual Report; Jan2005, p1-15, 15p

Record details

Cytokine discovery could halt inflammation and autoimmunity.

Subjects: CYTOKINES; IMMUNITY; UNIVERSITIES & collegesPENNSYLVANIA; UNITED States

• Source: PharmaWatch: Biotechnology; January 2004, Vol. 3 Issue 1, p17-17, 1p

Record details

AstraZeneca PLC SWOT Analysis.

• Source: AstraZeneca, PLC SWOT Analysis; 10/10/2024, p1-7, 7p

Record details

COMPANY SPOTLIGHT - Neurocrine Biosciences, Inc.

Subjects: LICENSE agreements; DRUG design; INDUSTRIAL propertyNEUROCRINE Biosciences Inc.

• Source: PharmaWatch: Biotechnology; October 2004, Vol. 3 Issue 10, p20-24, 5p

Record details

AstraZeneca PLC SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisLONDON (England)ASTRAZENECA PLC

• Source: AstraZeneca, PLC SWOT Analysis; 11/11/2023, p1-7, 7p

Record details

Neurology and Corrections.

• Authors : Jermstad, Todd

• Source: Correctional Health Care Report; Winter2024, Vol. 25 Issue 1, p1-23, 10p

Record details

AstraZeneca PLC. SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisLONDON (England)ASTRAZENECA PLC

• Source: AstraZeneca, PLC SWOT Analysis; 11/30/2022, p1-7, 7p

Record details

COMPANY PROFILE: AstraZeneca PLC SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisLONDON (England)ASTRAZENECA PLC

• Source: AstraZeneca, PLC SWOT Analysis; 11/22/2022, p1-7, 7p

Record details

AstraZeneca PLC SWOT Analysis.

Subjects: PHARMACEUTICAL industry; SWOT analysisLONDON (England)ASTRAZENECA PLC

• Source: AstraZeneca, PLC SWOT Analysis; 12/15/2021, p1-8, 8p

Record details